We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

212 hedge funds and large institutions have $1.45B invested in Corcept Therapeutics in 2018 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 66 increasing their positions, 68 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 32

12% more funds holding

Funds holding: 190 → 212 (+22)

10% more call options, than puts

Call options by funds: $10.8M | Put options by funds: $9.82M

3% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 68

1.33% less ownership

Funds ownership: 77.88% → 76.55% (-1.3%)

10% less capital invested

Capital invested by funds: $1.61B → $1.45B (-$159M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
212
Holders Change
+22
Holders Change %
+11.58%
% of All Funds
4.86%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
57
Increased
66
Reduced
68
Closed
32
Calls
$10.8M
Puts
$9.82M
Net Calls
+$1.02M
Net Calls Change
-$1.53M

Top Buyers

1
BlackRock
BlackRock
New York
+$27.9M
2
NC
Nexthera Capital
New York
+$19.4M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$15.4M
4
Deutsche Bank
Deutsche Bank
Germany
+$10.3M
5
Norges Bank
Norges Bank
Norway
+$8.82M

Top Sellers

1
Prudential Financial
Prudential Financial
New Jersey
-$23.4M
2
JIM
Jupiter Investment Management
United Kingdom
-$17.1M
3
BIM
Bogle Investment Management
Massachusetts
-$12.7M
4
TA
Teachers Advisors
New York
-$11.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
201
Nisa Investment Advisors
Missouri
$7K -$10.2K -550 -55%
FMII
202
Farmers & Merchants Investments Inc
Nebraska
$6K +$7.04K +380 New
RCAG
203
Rehmann Capital Advisory Group
Michigan
$4K +$4.24K +229 New
MOS
204
MGO One Seven
Ohio
$3K -$106K -5,722 -97%
QCG
205
Quadrant Capital Group
Ohio
$3K +$834 +45 +23%
KF
206
Krilogy Financial
Missouri
$3K +$3.71K +200 New
TWA
207
TCI Wealth Advisors
Arizona
$2K +$889 +48 +64%
TDC
208
Thompson Davis & Co
Virginia
$2K +$2.32K +125 New
MPWT
209
MassMutual Private Wealth & Trust
Connecticut
$1.69K +$1.91K +103 New
ASN
210
Advisory Services Network
Georgia
$1K +$871 +47 New
PFBT
211
Parkside Financial Bank & Trust
Missouri
$1K +$1.26K +68 New
BIM
212
Bogle Investment Management
Massachusetts
– -$12.7M -705,941 Closed
Fuller & Thaler Asset Management
213
Fuller & Thaler Asset Management
California
– -$7.95M -440,300 Closed
Two Sigma Investments
214
Two Sigma Investments
New York
– -$2.42M -133,732 Closed
CEP
215
Chicago Equity Partners
Illinois
– -$2.22M -123,010 Closed
EGM
216
Engineers Gate Manager
New York
– -$1.55M -85,654 Closed
AR
217
Advisory Research
Illinois
– -$1.16M -64,423 Closed
LCM
218
Landscape Capital Management
New Jersey
– -$1.14M -62,845 Closed
Jacobs Levy Equity Management
219
Jacobs Levy Equity Management
New Jersey
– -$891K -49,310 Closed
SIM
220
Spark Investment Management
New York
– -$751K -41,600 Closed
Jane Street
221
Jane Street
New York
– -$451K -24,960 Closed
SSWM
222
Sheets Smith Wealth Management
North Carolina
– -$436K -24,161 Closed
AWE
223
Avidian Wealth Enterprises
Texas
– -$436 -24,149 Closed
RG
224
Renaissance Group
Kentucky
– -$368K -20,381 Closed
BSW
225
Buckingham Strategic Wealth
Missouri
– -$361K -20,000 Closed
6 7 8
9
10

CORT Hedge Fund Activity: Q1 2018 in Review

212 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q1 2018, worth a combined $1.45B — down 9.9% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new CORT positions and 32 closed out — a net gain of 25 holders — while 66 added to existing stakes and 68 trimmed.

The largest buyer was BlackRock, adding an estimated $27.9M. The largest seller was Prudential Financial, cutting an estimated $23.4M.

  • 212 institutional investors held Corcept Therapeutics (CORT) as of Q1 2018, up from 190 in Q4 2017.
  • Funds reported $1.45B of Corcept Therapeutics stock for Q1 2018, down 9.9% quarter-over-quarter.
  • 57 funds opened new Corcept Therapeutics positions in Q1 2018 and 32 closed out, a net change of +25 holders.
  • The largest Corcept Therapeutics buyer in Q1 2018 was BlackRock, an estimated $27.9M added.
  • The largest Corcept Therapeutics seller in Q1 2018 was Prudential Financial, an estimated $23.4M sold.

Based on aggregated 13F filings for Q1 2018.